PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA.\', \'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.\', \'Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.\', \'Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01655, USA.\', \'Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA; Howard Hughes Medical Institute. Electronic address: nussen@mail.rockefeller.edu.\', \'Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Electronic address: bjorkman@caltech.edu.\', \'Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA. Electronic address: thatziio@rockefeller.edu.\', \'Laboratory of Retrovirology, The Rockefeller University, New York, NY 10065, USA; Howard Hughes Medical Institute. Electronic address: pbieniasz@rockefeller.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1074-7613(21)00294-610.1016/j.immuni.2021.07.008
?:doi
?:hasPublicationType
?:journal
  • Immunity
is ?:pmid of
?:pmid
?:pmid
  • 34331873
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 13.393
?:rankingScore_hIndex
  • 342
is ?:relation_isRelatedTo_publication of
?:title
  • Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all